Who owns NBIX
678 institutions reported holding NBIX for 2026Q1, together 96% of the company, fewer than the 716 a quarter earlier.
678
Institutions reporting a position · as of 2026Q1 · down from 716 the quarter before
- Shares held by institutions
- 99.3M
Shares held by institutions · 96% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $13.1B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 38%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 77
- Positions exited
- 116
- Added to
- 274
- Reduced
- 202
- Top 10 holdersof the company
- 51%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 678 | 99.3M | $13.1B |
| 2025Q4 | 716 | 98.9M | $14.0B |
| 2025Q3 | 637 | 96.5M | $13.5B |
| 2025Q2 | 573 | 98.4M | $12.4B |
| 2025Q1 | 578 | 95.5M | $10.6B |
| 2024Q4 | 592 | 94.1M | $12.8B |
| 2024Q3 | 563 | 92.1M | $10.6B |
| 2024Q2 | 582 | 93.0M | $12.8B |
| 2024Q1 | 575 | 92.9M | $12.8B |
| 2023Q4 | 544 | 91.9M | $12.1B |
| 2023Q3 | 501 | 91.2M | $10.3B |
| 2023Q2 | 450 | 91.0M | $8.61B |
| 2023Q1 | 481 | 90.0M | $9.07B |
| 2022Q4 | 526 | 89.3M | $10.7B |
| 2022Q3 | 463 | 89.6M | $9.52B |
| 2022Q2 | 433 | 89.1M | $8.68B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Inc. | 13.4M | 13% | $1.76B |
| VANGUARD GROUP INC | 10.0M | 9.7% | $1.32B |
| Dodge & Cox | 5.5M | 5.3% | $719M |
| JPMORGAN CHASE & CO | 5.4M | 5.3% | $701M |
| AQR CAPITAL MANAGEMENT LLC | 4.9M | 4.8% | $651M |
| STATE STREET CORP | 4.4M | 4.2% | $574M |
| TWO SIGMA INVESTMENTS, LP | 3.1M | 3.0% | $403M |
| RENAISSANCE TECHNOLOGIES LLC | 2.4M | 2.3% | $319M |
| GEODE CAPITAL MANAGEMENT LLC | 2.1M | 2.1% | $281M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.5M | 1.4% | $197M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - Specialty & Generic
Ranks #8 of 28 by Smart Score